Neurocrine Biosciences
NBIX
#1660
Rank
ยฃ9.61 B
Marketcap
ยฃ95.75
Share price
-2.09%
Change (1 day)
38.11%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.2500% (annualized)

Shares available to borrow: 3400000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2026 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Pfizer
PFE
0.2613%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.4081%7.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.4081%3.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0.4135%0.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.2553%0.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
4.6124%0 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.4081%6.6 M๐Ÿ‡ฌ๐Ÿ‡ง UK